Custom Phosphoramidites for Antisense Oligonucleotides, siRNA, and Gene Therapy
The global phosphoramidite market, valued at USD 1.10 billion in 2024, is anticipated to expand at a CAGR of 8.13% from 2025 to 2034, with growth increasingly driven by segment-wise performance across product types, end-user applications, and technological platforms. Phosphoramidites are categorized by nucleoside base (adenine, cytosine, guanine, thymine, uracil), modification...
0 التعليقات 0 المشاركات 18 مشاهدة 0 معاينة